Last --
Change Today 0.00 / 0.00%
Volume 0.0
3LT On Other Exchanges
Symbol
Exchange
London
Berlin
London
All times are local (Market data is delayed by at least 15 minutes).

lifeline scientific inc (3LT) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LIFELINE SCIENTIFIC INC (3LT)

Related News

No related news articles were found.

lifeline scientific inc (3LT) Related Businessweek News

No Related Businessweek News Found

lifeline scientific inc (3LT) Details

Lifeline Scientific, Inc., a medical technology company, provides products and services for cell, tissue, and organ transplantation and research in the United States and internationally. It offers Lifeport Kidney Transporter, a medical device that provides enhanced kidney preservation, evaluation, and transport prior to transplantation. The company also provides single-use disposable products and organ preservation solutions. In addition, it is involved in the research and development of preservation technologies for transplantable biological materials; and scientific research for in vitro diagnostics, and allograft cells and tissues, such as heart valves, saphaneous veins, and cartilage and pancreatic islets for transplantation. The company was formerly known as Organ Recovery Systems, Inc. and changed its name to Lifeline Scientific, Inc. in December 2007. Lifeline Scientific, Inc. was founded in 1998 and is based in Itasca, Illinois.

Founded in 1998

lifeline scientific inc (3LT) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lifeline scientific inc (3LT) Key Developments

Lifeline Scientific, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2013

Lifeline Scientific, Inc. reported consolidated earnings results for the year ended December 31, 2013. For the year, the company reported total revenue of $33,233,313 against $30,151,843 a year ago. Income from operations was $1,942,620 against $127,447 a year ago. Income before income taxes was $1,854,358 against $45,899 a year ago. Net Income (Loss) attributable to the company was $2,856,541 or $0.14 per diluted share against net loss of $210,844 or $0.01 per diluted and basic share a year ago. Net cash used in operating activities was $377,308 compared to $1,471,828 reported a year ago. Capital expenditures were $1,045,626 compared to $1,685,848 reported a year ago. Payments related to intangible assets and legal fees associated with patent filings were $1,090,624 against $811,001 a year ago. Operating profit improved significantly to $1.9 million due to sales growth, the result of a non-recurring legal settlement, and a reduction in research and development for the year.

Lifeline Scientific, Inc., Annual General Meeting, Jun 19, 2014

Lifeline Scientific, Inc., Annual General Meeting, Jun 19, 2014., at 08:30 Central Standard Time. Location: Westin Hotel.

Lifeline Scientific, Inc. to Report Fiscal Year 2013 Results on Apr 29, 2014

Lifeline Scientific, Inc. announced that they will report fiscal year 2013 results on Apr 29, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3LT:GR €0.00 EUR 0.00

3LT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3LT.
View Industry Companies
 

Industry Analysis

3LT

Industry Average

Valuation 3LT Industry Range
Price/Earnings 21.6x
Price/Sales 1.8x
Price/Book 2.9x
Price/Cash Flow 7.2x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIFELINE SCIENTIFIC INC, please visit www.lifeline-scientific.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.